Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas

Author: Desjardins Annick   Quinn Jennifer   Vredenburgh James   Sathornsumetee Sith   Friedman Allan   Herndon James   McLendon Roger   Provenzale James   Rich Jeremy   Sampson John   Gururangan Sridharan   Dowell Jeannette   Salvado August   Friedman Henry   Reardon David  

Publisher: Springer Publishing Company

ISSN: 0167-594X

Source: Journal of Neuro-Oncology, Vol.83, Iss.1, 2007-05, pp. : 53-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content